Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom
# Background Gastro-oesophageal reflux disease (GORD) is a common condition associated with heartburn and regurgitation. Standard of care for GORD patients in the UK involves initial treatment with proton pump inhibitors (PPIs) and laparoscopic antireflux surgery in patients unwilling to continue or...
Saved in:
Main Authors: | Sam Harper, Lukasz Grodzicki, Stuart Mealing, Elizabeth Gemmill, Paul Goldsmith, Ahmed Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-01-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.90924 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of low compliance with treatment in the patients with gastro-esophageal reflux disease
by: S. V. Tikhonov
Published: (2013-09-01) -
Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01) -
COMBINATION OF CONSERVATIVE AND SURGICAL TREATMENT OF REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE
by: NATALIA B. Gubergrits, et al.
Published: (2017-06-01) -
Association between infection of Helicobacter pylori and the risk of reflux oesophagitis occurrence or recurrence: a systematic review and meta-analysis
by: Yanan Zhang, et al.
Published: (2025-06-01) -
Current management of proton pump inhibitor-refractory gastroesophageal reflux disease
by: V. V. Tsukanov, et al.
Published: (2020-06-01)